|Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements|
EM Agger, I Rosenkrands, J Hansen, K Brahimi, BS Vandahl, C Aagaard, ...
PloS one 3 (9), e3116, 2008
|Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3|
C Roussilhon, C Oeuvray, C Müller-Graf, A Tall, C Rogier, JF Trape, ...
PLoS medicine 4 (11), e320, 2007
|Antigenic equivalence of human T-cell responses toMycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of …|
SM Arend, A Geluk, KE van Meijgaarden, JT van Dissel, M Theisen, ...
Infection and immunity 68 (6), 3314-3321, 2000
|Epitope mapping of the immunodominant antigen TB10. 4 and the two homologous proteins TB10. 3 and TB12. 9, which constitute a subfamily of the esat-6 gene family|
RLV Skjøt, I Brock, SM Arend, ME Munk, M Theisen, THM Ottenhoff, ...
Infection and immunity 70 (10), 5446-5453, 2002
|Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal|
C Oeuvray, M Theisen, C Rogier, JF Trape, S Jepsen, P Druilhe
Infection and immunity 68 (5), 2617-2620, 2000
|Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses …|
S Soe, M Theisen, C Roussilhon, P Druilhe
Infection and immunity 72 (1), 247-252, 2004
|The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro|
M Theisen, S Soe, C Oeuvray, AW Thomas, J Vuust, S Danielsen, ...
Infection and immunity 66 (1), 11-17, 1998
|Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria …|
I Nebie, A Diarra, A Ouedraogo, I Soulama, EC Bougouma, AB Tiono, ...
Infection and immunity 76 (2), 759-766, 2008
|Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies|
MF Muellenbeck, B Ueberheide, B Amulic, A Epp, D Fenyo, CE Busse, ...
Journal of Experimental Medicine 210 (2), 389-399, 2013
|Polymorphism in ospC gene of Borrelia burgdorferi and immunoreactivity of OspC protein: implications for taxonomy and for use of OspC protein as a diagnostic antigen.|
M Theisen, B Frederiksen, AM Lebech, J Vuust, K Hansen
Journal of Clinical Microbiology 31 (10), 2570-2576, 1993
|Analysis of the OspE determinants involved in binding of factor H and OspE-targeting antibodies elicited during Borrelia burgdorferi infection in mice|
MS Metts, JV McDowell, M Theisen, PR Hansen, RT Marconi
Infection and immunity 71 (6), 3587-3596, 2003
|Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli.|
M Theisen, J Vuust, A Gottschau, S Jepsen, B Høgh
Clin. Diagn. Lab. Immunol. 2 (1), 30-34, 1995
|Naturally Acquired Antibodies to the Glutamate-Rich Protein Are Associated with Protection against Plasmodium falciparum Malaria|
D Dodoo, M Theisen, JAL Kurtzhals, BD Akanmori, KA Koram, S Jepsen, ...
The Journal of infectious diseases 181 (3), 1202-1205, 2000
|Cohort study of the association of antibody levels to AMA1, MSP1 19, MSP3 and GLURP with protection from clinical malaria in Ghanaian children|
D Dodoo, A Aikins, KA Kusi, H Lamptey, E Remarque, P Milligan, ...
Malaria journal 7 (1), 142, 2008
|Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial|
CC Hermsen, DF Verhage, DSC Telgt, K Teelen, JT Bousema, ...
Vaccine 25 (15), 2930-2940, 2007
|Safety and immunogenicity of GMZ2—a MSP3–GLURP fusion protein malaria vaccine candidate|
M Esen, PG Kremsner, R Schleucher, M Gässler, EB Imoukhuede, ...
Vaccine 27 (49), 6862-6868, 2009
|A Plasmodium falciparum GLURP–MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies|
M Theisen, S Soe, K Brunstedt, F Follmann, L Bredmose, H Israelsen, ...
Vaccine 22 (9-10), 1188-1198, 2004
|Identification of a Conserved Region of Plasmodium falciparum MSP3 Targeted by Biologically Active Antibodies to Improve Vaccine Design|
S Singh, S Soe, JP Mejia, C Roussilhon, M Theisen, G Corradin, ...
Journal of Infectious Diseases 190 (5), 1010-1018, 2004
|Identification and characterization of a 29-kilodalton protein from Mycobacterium tuberculosis culture filtrate recognized by mouse memory effector cells|
I Rosenkrands, PB Rasmussen, M Carnio, S Jacobsen, M Theisen, ...
Infection and immunity 66 (6), 2728-2735, 1998
|Evolution of the Borrelia burgdorferi outer surface protein OspC.|
M Theisen, M Borre, MJ Mathiesen, B Mikkelsen, AM Lebech, K Hansen
Journal of Bacteriology 177 (11), 3036-3044, 1995